Dr. Natu R Patel, M.D Family Medicine Medicare: Medicare Enrolled Practice Location: 2792 Egypt Road, Audubon, PA 19403 Phone: 610-666-9240 Fax: 610-666-1808 |
Dr. Manjit Singh, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10000 Shannondell Dr, Audubon, PA 19403 Phone: 610-728-5241 Fax: 610-728-5322 |
Nilesh V. Patel, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2793 Egypt Rd, Suite 409, Audubon, PA 19403 Phone: 610-666-1400 Fax: 610-666-1445 |
Dr. Merlyn Ancilla Johnson, M.D Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2792 Egypt Rd, Audubon, PA 19403 Phone: 610-666-9240 Fax: 610-666-1808 |
Dana Burkholder, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 20000 Shannondell Dr, Audubon, PA 19403 Phone: 484-392-4045 Fax: 484-392-4049 |
Dr. John Edward Peacock Iii, D.O. Family Medicine - Geriatric Medicine Medicare: Medicare Enrolled Practice Location: 10000 Shannondell Dr, Audubon, PA 19403 Phone: 610-728-5241 Fax: 610-728-5322 |
News Archive
"Healthy Quest is designed to focus on health issues that 'drive a lot of costs, and drive a lot of lost productivity,' like obesity, smoking and stress, [Steve Burton, vice president of health and wellness services at Quest Diagnostics] said."
Physicians at more than 40 centers in France have joined a study of the CATANIA(TM) Coronary Stent with NanoThin Polyzene®-F manufactured by CeloNova BioSciences. With Professor Emmanuel Teiger and Doctor Paul Barragan as co-Principal Investigators, the researchers today announced the Assessment of The Latest Non-Thrombogenic Angioplasty (ATLANTA-France) stent study. Each center will enroll 50 patients with the first procedures expected in early November.
Another influenza pandemic is on the third spot of the list of 10 health threats collated by the World Health Organization for 2019.
Researchers in Canada have conducted a study suggesting that novel Cannabis sativa extracts may decrease levels of the host cell receptor that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses to gain viral entry to target tissues.
The Government needs to resolve a number of issues to ensure the health service can cope with a national bowel screening programme, a leading Cancer Research UK scientist will tell conference delegates today (Tuesday).
› Verified 9 days ago